National Bank of Canada FI Lowers Position in Chemed Co. (NYSE:CHE)

National Bank of Canada FI decreased its position in shares of Chemed Co. (NYSE:CHE) by 11.6% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 2,200 shares of the company’s stock after selling 289 shares during the period. National Bank of Canada FI’s holdings in Chemed were worth $1,166,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. HighTower Advisors LLC raised its holdings in Chemed by 78.0% in the third quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock worth $2,246,000 after purchasing an additional 1,634 shares in the last quarter. Quantinno Capital Management LP grew its position in shares of Chemed by 29.9% in the 3rd quarter. Quantinno Capital Management LP now owns 1,587 shares of the company’s stock worth $954,000 after buying an additional 365 shares during the period. Stifel Financial Corp increased its stake in shares of Chemed by 1.0% in the 3rd quarter. Stifel Financial Corp now owns 26,996 shares of the company’s stock worth $16,224,000 after acquiring an additional 273 shares in the last quarter. State Street Corp lifted its position in Chemed by 0.8% during the 3rd quarter. State Street Corp now owns 464,354 shares of the company’s stock valued at $279,063,000 after acquiring an additional 3,564 shares during the period. Finally, EP Wealth Advisors LLC boosted its stake in Chemed by 1.9% during the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock worth $814,000 after acquiring an additional 25 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of the business’s stock in a transaction on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the transaction, the chief executive officer now owns 101,679 shares in the company, valued at $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 3.32% of the stock is currently owned by insiders.

Chemed Stock Performance

NYSE:CHE opened at $571.72 on Wednesday. The firm has a market cap of $8.37 billion, a P/E ratio of 28.89, a P/E/G ratio of 2.15 and a beta of 0.49. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $627.12. The firm has a 50-day simple moving average of $580.74 and a two-hundred day simple moving average of $567.86.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. Chemed’s payout ratio is currently 10.05%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada lifted their price objective on Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a research note on Friday, March 14th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.